Delineating the molecular mechanism(s) of a potent anti-EGFR/HER2/KRAS strategy against undruggable and incurable human cancer in preclinical settings

Author: Maurice Johnson

Program: Medicine

Mentor(s): Amy Tang, PhD

Session: B

Time: 3:40 p.m.